Accessibility navigation


Modulation of the human gut microflora towards improved health using prebiotics: assessment of efficacy

Tuohy, K.M., Rouzaud, G.C.M., Bruck, W.M. and Gibson, G.R. (2005) Modulation of the human gut microflora towards improved health using prebiotics: assessment of efficacy. Current Pharmaceutical Design, 11 (1). pp. 75-90. ISSN 1381-6128

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Official URL: http://www.bentham.org/cpd/

Abstract/Summary

There is increasing awareness that the human gut microflora plays a critical role in maintaining host health, both within the gastrointestinal tract and, through the absorption of metabolites, systemically. An 'optimal' gut microflora establishes an efficient barrier to the invasion and colonisation of the gut by pathogenic bacteria, produces a range of metabolic substrates which in turn are utilized by the host (e.g. vitamins and short chain fatty acids) and stimulates the immune system in a non-inflammatory manner. Although little is known about the individual species of bacteria responsible for these beneficial activities, it is generally accepted that the bifidobacteria and lactobacilli constitute important components of the beneficial gut microflora. A number of diet-based microflora management tools have been developed and refined over recent decades including probiotic, prebiotic and synbiotic approaches. Each aims to stimulate numbers and/or activities of the bifidobacteria and lactobacilli within the gut microflora. The aim of this article is to examine how prebiotics are being applied to the improvement of human health and to review the scientific evidence supporting their use.

Item Type:Article
Refereed:Yes
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > Department of Food and Nutritional Sciences
ID Code:12922
Uncontrolled Keywords:prebiotic, oligosaccharides, gut microflora, bifidobacteria, functional, food, ABERRANT CRYPT FOCI, SHORT-CHAIN FRUCTOOLIGOSACCHARIDES, INCREASES, FECAL BIFIDOBACTERIA, ACID-CONTAINING SUBSTANCES, HEPATIC, GLUCOSE-PRODUCTION, CONTINUOUS-CULTURE SYSTEM, IN-VITRO FERMENTATION, HUMAN LARGE-INTESTINE, FISHER 344 RATS, ULCERATIVE-COLITIS

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation